About NOVAREX
NOVAREX is a publicly listed company based in Cheongju-si (South Korea) founded in 2008. Nutritional functional ingredients are supplied for health foods and products. The company has 444 employees. Its website novarex.co.kr draws about 22 thousand monthly visits. Its focus areas include Life Sciences, Nutraceuticals Tech, Nutraceutical Ingredients and Functional Food Ingredients.
Company details
NOVAREX was founded in 2008 and is based in Cheongju-si, South Korea. Functional ingredients for nutritional foods and healthcare products are provided through standardization of raw materials. Development focuses on sources derived from animals, plants, and microorganisms. Operations center on the health functional foods sector, supporting ingredient needs for various applications.
- Headquarters Cheongju-si, South Korea
- Employees 444
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website novarex.co.kr
- Legal Name Novarex Co., Ltd.
- Annual Revenue$279.92 M (USD)35.78as on Dec 31, 2025
- Net Profit$24.53 M (USD)53.87as on Dec 31, 2025
- EBITDA$36.48 M (USD)62.37as on Dec 31, 2025
- Employee Count444
IPO & Listings of NOVAREX
NOVAREX is a publicly listed company on the KRX with ticker symbol 194700 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date02 Nov 2018
- Listed onKRX: 194700
- Listed entityNOVAREX Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7194700001
- Share price10,010.00 KRW (-0.4% on the day) · 2026-10-14
- Market capitalisation183,461,227,226.00 KRW
- Price to earnings4.2
- EPS (diluted, trailing year)2,396.99 KRW
- Dividend yield3.85%
- Volume (last session)25,600
Financials of NOVAREX
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 404.26B KRW | 35.42B KRW | 52.69B KRW |
| 2024 | 297.73B KRW | 23.02B KRW | 32.45B KRW |
| 2023 | 302.17B KRW | 22.04B KRW | 33.95B KRW |
| 2022 | 281.68B KRW | 19.99B KRW | 32.94B KRW |
| 2021 | 278.79B KRW | 26.40B KRW | 35.81B KRW |
Detailed financial statements for NOVAREX
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of NOVAREX
The website of NOVAREX (novarex.co.kr) receives about 21.7K visits a month.
- Monthly visits21.7K
▲ 24.8% vs previous month
Websites whose visitors overlap most with NOVAREX. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biotimes.co.kr | 100% | #456,742 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novarex
Complete news archive for NOVAREX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NOVAREX
NOVAREX was founded in 2008.
NOVAREX is headquartered in Cheongju-si, South Korea. It is registered at Cheongju-si, North Chungcheong, South Korea.
NOVAREX has 444 employees.
Annual revenue of NOVAREX is $279.92M as on Dec 31, 2025.
NOVAREX was founded in 2008 and is based in Cheongju-si, South Korea. Functional ingredients for nutritional foods and healthcare products are provided through standardization of raw materials. Development focuses on sources derived from animals, plants, and microorganisms. Operations center on the health functional foods sector, supporting ingredient needs for various applications.
Yes, NOVAREX is publicly traded on KRX under the ticker symbol 194700.